13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)

Page 2 of 8 – SEC Filing

CUSIP
No.  00548A106
13G/A Page
2 of 7 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

37-1475292

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)

o

(b)

o

3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

256,340

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

256,340

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

256,340

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
(See Instructions)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

1.14%1

12.

TYPE OF REPORTING PERSON (See Instructions)

IA

1 Based on a total
of 22,514,076 shares outstanding, as reported by the Issuer on a Form 10-Q filed with the SEC on May 9, 2017.

Follow Adamas Pharmaceuticals Inc (NASDAQ:ADMS)